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Abstract
Within Europe large differences exist in mortality from coronary heart disease and
stroke. These diseases show a clear West-East gradient with high rates in Eastern
Europe. In spite the decreasing trend in age-adjusted cardiovascular disease
mortality in Western European countries an increase in the number of cardiovascular
patients is expected because of the ageing of the population. Consequently the
health care cost for these diseases will increase.
Total and HDL cholesterol are major determinants of coronary heart disease.
Saturated and trans fatty acids have a total and LDL cholesterol elevating effect and
unsaturated fatty acids a lowering effect. N-3 polyunsaturated fatty acids seem to
have a protective effect on coronary heart disease occurrence independent of their
effect on cholesterol.
Dietary antioxidants could be of importance because they may prevent oxidation of
the atherogenic cholesterol rich LDL lipoproteins. There is however no convincing
evidence that either vitamin E, carotenoids or vitamin C protect against coronary
heart disease. Observational research has shown that flavonols, polyphenols with
strong antioxidant properties present in plant foods, may protect against coronary
heart disease.
Blood pressure is a major determinant of coronary heart disease and stroke.
Historically salt is viewed as the most important dietary determinant of blood
pressure. Recent research shows that also a low-fat diet rich in potassium, calcium
and magnesium lowers blood pressure substantially. This suggests a multifactorial
influence of different nutrients on blood pressure.
It can be concluded that a diet low in saturated and trans fatty acids and rich in plant
foods in combination with regular fish consumption is associated with a low risk of
cardiovascular mortality.
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Introduction
In most European countries cardiovascular diseases
contribute about 40% to all cause mortality. Within this
category of diseases the two most important ones are
coronary heart disease and stroke. Coronary heart disease
contributes about 50% to total cardiovascular diseases and
stroke about 25%. In this chapter the epidemiology of
both coronary heart disease and stroke will be described.
Systematic studies on the epidemiology of cardiovas-
cular diseases e.g. the Framingham Study in the USA and
the Seven Countries Study were initiated about 50 years
ago. An enormous literature on the epidemiology of
cardiovascular diseases is available. In this chapter the
epidemiology of these diseases will be succinctly
summarised with an emphasis on dietary determinants.
Because nutrition is strongly related to other behavioural
risk factors e.g. smoking, alcohol and physical activity,
these risk factors will be also touched upon as well as
lifestyle related biological risk factors e.g. total and HDL
cholesterol, blood pressure and body mass index.
This chapter deals with the burden of cardiovascular
diseases in Europe, secular trends and future develop-
ments, biological risk factors, dose-response relations,
behavioural risk factors and dietary prevention of
cardiovascular diseases.
The burden of cardiovascular diseases in Europe
Within Europe large differences exist in mortality from
coronary heart disease and stroke1. Generally mortality
differences between populations are analysed at the
country level. However, recently the results on spatial
analyses of mortality patterns in Europe have become
available. The advantage of this type of analysis is that
regional variability in mortality patterns can be shown
across borders of countries. This may help in identifying
factors responsible for this variation. Regional
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Fig. 1 Age-standardized mortality from coronary heart disease (ICD 410–414) in European regions in 1990–91. All ages. (a) men; (b) women. Reproduced with permission from Sans et al.1
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age-standardised mortality data are available for the years
1990 and 1991. This data was averaged in order to obtain
more stable rates. Maps are presented for coronary heart
disease and stroke mortality separately.
Coronary heart disease mortality patterns show a clear
West- East gradient in both men and women with the
highest mortality rates in Eastern Europe (Fig. 1a and b).
The ratio between the 90th and the 10th percentile was
about 5. The distribution shows that the differences in
regional mortality rates within Western Europe are
relatively small compared to Eastern Europe. In the
United Kingdom, a distinct North-South gradient is noted.
For stroke mortality also a West-East pattern can be
observed in both men and women (Fig. 2a and b). There
are, however, exceptions. High stroke mortality rates are
still observed in Portugal and to a lesser extent in other
Mediterranean regions. In contrast to coronary heart
disease, the lowest stroke rates were observed in North-
ern and Western European countries e.g. Sweden, Den-
mark, The Netherlands and Germany. The ratio between
the 90th and 10th percentile was about 5 in both men and
women.
In order to get insight into the burden of cardiovascular
diseases in Europe it is necessary to get information not
only on mortality patterns but also on morbidity patterns.
However standardised morbidity rates are much more
difficult to obtain than mortality rates. One of the aims of
the WHO MONICA project was to obtain valid informa-
tion on coronary event rates in different populations. The
total event rates collected in the MONICA study are a
good indicator of comparative incidence2. However the
best indicator of the burden of cardiovascular diseases
would be the number of prevalent cases present in the
population. Reliable and comparable estimates of the
number of prevalent cases of cardiovascular diseases in
Europe are however not available.
Results of the MONICA study showed that 1.0 to 1.5
episodes of hospitalised non-fatal, definite myocardial
infarction were registered for every death due to coronary
heart disease2. The age-standardised annual event rate
ranged in men from 915 per 100 000 in North Karelia
(Finland) to 187 per 100 000 in Catalonia (Spain) and in
women from 256 per 100 000 in Glasgow (UK) to 30 per
100 000 in Catalonia (Spain). The event rates of definite
non-fatal myocardial infarction in the different MONICA
regions correlated well with the coronary heart disease
mortality rates based on official death certificates.
To get a reliable estimate of the number of patients with
e.g. myocardial infarction is difficult. In a study carried out
by a network of GP’s in the Netherlands it was shown that
the percentage of definite cases of myocardial infarction is
only about 50% of the suspected number of cases3. In the
Netherlands the current annual number of incident cases
of acute myocardial infarction is estimated to be about
25.000 and the number of prevalent cases of coronary
heart disease is currently about 150.0004. This shows that
information about the number of prevalent cases is
needed in order to get a good estimate of the total
burden of a disease in a population.
Secular trends and future developments in
cardiovascular diseases
Mortality trends for coronary heart disease and stroke
have been reported by the Task Force of the European
Society of Cardiology1. For reasons of clarity nine
indicator countries were selected to illustrate long-term
trends in mortality rates since 1970. The following nine
indicator countries represent the large variety in trends;
for Central and Eastern Europe, the Russian Federation,
the former Czechoslovakia and Hungary, for Western
Europe, Denmark and England and Wales; for Northern
Europe, Finland; and for Southern Europe; Portugal,
Spain and Greece (Fig. 3a and b).
Finland had the highest mortality rate from coronary
heart disease of all European countries in 1970, but had
intermediate rates 22 years later. Decreasing trends were
also observed in Denmark and England and Wales; but
there the decline started later than in Finland. Large
increases were observed in Central and Eastern European
countries, such as Hungary and the former Czechoslova-
kia. The very high rates in the Russian Federation and the
rapid increase since 1990 are noticeable. Portugal, Spain
and Greece had very low rates during the whole period.
Similar trends were observed in women. However, the
increasing trend in Central and Eastern Europe was less
pronounced in women compared with men (Fig. 3b).
In the same period substantial differences in stoke
mortality were observed between different countries (Fig.
4a and b). Stroke mortality rates increased until about
1985 in Hungary and the former Czechoslovakia. There-
after the stroke mortality rates among men declined in
Hungary, the former Czechoslovakia and the Russian
Federation until about 1990. After 1990 the rates started to
increase again in Hungary and the Russian Federation.
Consistently decreasing trends were observed in Portugal,
Finland, Spain, England and Wales. During the 23-year
period persistent low rates were observed in Greece and
Denmark. Similar trends were observed in women
(Fig. 4b).
In 1990 there were world-wide 6.3 million of deaths
due to coronary heart disease and 4.4 million due to
stroke on a total of 50.5 million deaths5. Murray and
Lopez predict that these two diseases will remain the
leading causes of death at least till 20206. In order to
assess the public health importance of different diseases
Murray and Lopez used as a standard unit, the disability
adjusted life years (DALY)7. Cardiovascular diseases
contributed 18.5% to all DALY’s in the established market
economies of Europe. This means that cardiovascular
diseases are not only a major cause of death but are also
major contributors to ill health and disability.
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Projections on the future burden of coronary heart
disease and stroke are not available for different
European countries. Demographic projections have
been made for the Netherlands4. It is expected that
between 1994 and 2015 the number of prevalent cases of
coronary heart disease and stroke will increase with 35–
45%. If we take 40% as the best estimate the number of
prevalent cases of coronary heart disease will increase
from about 150.000 to 210.000 and of stroke patients from
about 85.000 to 119.000. This shows that in spite of
decreasing age- standardised mortality rates the number
of cardiovascular disease patients will increase substan-
tially in the decades to come. This is the consequence of
the ageing of the Dutch population and a decreased case
fatality because of successful treatment of cardiovascular
patients. Similar trends are observed in other Western
European countries. Besides the already dramatic situ-
ation in relation to cardiovascular diseases in Eastern
Europe it is expected that also in Western European
countries the number of cardiovascular patients will
increase. It may therefore be concluded that we will be
confronted with a large increase in the number of
cardiovascular patients in the years to come.
Biological risk factors for cardiovascular diseases
Classic epidemiologic studies have shown that serum
cholesterol and blood pressure are important risk factors
for coronary heart disease. Blood pressure is also a major
determinant of stroke. In observational epidemiology
serum cholesterol is not related to stroke. However, if
information on the type of stroke is available, haemorra-
gic stroke seems to be inversely related with serum
cholesterol and thrombotic stroke positively.
Cholesterol is transported in different lipoprotein
fractions. The Low Density Lipoprotein (LDL) fraction is
rich in cholesterol. Experimental research has shown that
oxidised LDL (oxLDL) is a major determinant of athero-
sclerosis8. Because of the strong correlation between LDL
cholesterol and total cholesterol the later can be viewed
as an indicator of LDL cholesterol.
Of the other lipoprotein fractions the High Density
Lipoproteins (HDL) were shown to be inversely related
with coronary heart disease occurrence. Experimental
research has shown that HDL is involved in the reverse
transport of cholesterol from the peripheral tissues to the
liver. In the liver cholesterol can be metabolised to bile
acids and be excreted. Based on the results of both
epidemiologic and experimental research it can be
concluded that the total/HDL cholesterol ratio is the
best predictor of the effect of lipid metabolism on
coronary heart disease risk9.
Blood pressure has been identified as one of the major
risk factors for both coronary heart disease and stroke.
Observational and experimental studies have shown that
diastolic blood pressure is a strong predictor of both
coronary heart disease and stroke10,11. Casually measured
systolic blood pressure is stronger related to cardiovas-
cular endpoints than diastolic blood pressure12. An
explanation for this difference in predictive power could
be less measurement error in the determination of systolic
compared with diastolic blood pressure.
Body fat has been viewed as a risk factor for coronary
heart disease for a long time. Generally Body Mass Index
BMI  weight=height2 is used as an indicator of body fat
in epidemiologic studies. However the results of epi-
demiologic studies on the relation between BMI and
coronary heart disease are not unequivocal. The strength
of the association seems to decrease with age. However,
in both men and women with an average age of 40 years
the risk on coronary heart disease mortality is positively
associated with BMI from a BMI of 18.5 and higher13. This
association is strongest in non-smokers. There is no
convincing evidence that BMI is a risk factor for stroke.
It can be concluded that in middle age total cholesterol,
HDL cholesterol, blood pressure and BMI are important
risk factors for coronary heart disease. For these risk
factors blood pressure is the only one that is convincingly
related with stroke. Since the beginning of the epidemiol-
ogy of cardiovascular diseases information has been
collected on total cholesterol, blood pressure and BMI.
The levels and the trends in these risk factors in Europe
can therefore be described.
Standardised information on these biological risk
factors has been collected in the Seven Countries and
the MONICA Study2,14–16. The Seven Countries Study
started in 1958 and the MONICA Study in the 1980s.
MONICA data are used to describe the current situation in
Europe and the short-term trends in biological risk factors.
The Seven Countries Study and the MONICA data are
used to describe the long-term trends in biological risk
factors in middle-aged men.
Around 1995 mean serum total cholesterol levels were
the highest in Central Europe and lowest in Southern
Europe (e.g. 6.4 mmol/l in Novi Sad, Serbia and
5.6 mmol/l in Catalonia, Spain, Table 1). High total
cholesterol levels ($7.8 mmol/l) varied from 13% in
Novi Sad to 3% in Catalonia.
Mean systolic blood pressure levels did not show a
clear North-South gradient. High levels were observed in
both Northern (North Karelia, Finland) and Southern
(Friuli, Italy) Europe. The same holds for low levels that
were also observed in both in Northern (Iceland) and in
Southern (Catalonia, Spain) Europe. Large variations were
present with respect to the prevalence of hypertension
(systolic BP $160 mmHg and/or diastolic BP $95 mmHg
and/or antihypertensive medication). This varied
between 36% in North Karelia and 10% in Catalonia.
Body Mass Index did not vary much between the
different populations. Both the highest and the lowest
average values were found in Northern Europe e.g. in
North Karelia (27.5 kg/m2) and Glostrup, Denmark
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Fig. 2 Age-standardized mortality from stroke (ICD 430–438) in European regions in 1990–91. All ages. (a) men; (b) women. Reproduced with permission from Sans et al.1
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(26.0 kg/m2). The prevalence of obesity (BMI $30 kg/
m2) varied between 23% in North Karelia and 13% in
Glostrup.
Information on the trends in biological risk factors in
the period 1985–1995 was recently published by the
MONICA investigators16. For serum total cholesterol an
average decrease of about 0.4 mmol/l during 10 years
was observed in Finland (Table 2). A smaller decrease
was observed in most Western European countries. The
average changes in systolic blood pressure varied during
the 10 year period from a 13.5 mmHg decrease in Warsaw
(Poland) to a 5 mmHg increase in Novi Sad (Serbia). With
Fig. 3 Time-trends in mortality from coronary heart disease in selected countries. 1970–92. Age 45–74 years. (a) men; (b) women.
Reproduced with permission from Sans et al.1
Fig. 4 Time-trends in age-standardized mortality from stroke in selected countries. 1970–92. Age 45–74. (a) men; (b) women. Reproduced
with permission from Sans et al.1
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the exception of Kaunas (Lithuania) an increase in
average BMI was observed. The largest increase between
1985 and 1995 was observed in Ghent (Belgium) and
amounted to 1.4 kg/m2. This is equivalent to an average
increase in body weight of about 4 kg during a 10-year
period.
Information on the long-term trends of biological risk
factors in middle-aged men could be obtained by
comparing data from the baseline survey of the Seven
Countries Study carried out around 1960 and the MONICA
surveys carried out in the period 1985–1995. Some
remarkable trends are noted. During this 35 year period
mean total cholesterol levels in Finland did decrease with
0.7 mmol/l (Table 3). No change was found comparing
data from the Netherlands and Belgium. An increase in
mean total cholesterol level was observed in Italy and
Serbia. In Serbia the average serum total cholesterol level
increased by more than 2 mmol/l. Similar longitudinal
changes were observed in the Finnish, Dutch, Italian and
Serbian cohorts of the Seven Countries Study17,18.
Table 1 Mean levels of biological risk factors for coronary heart disease in men aged 35–64 years in European populations around 1995
(The WHO MONICA Project16)
Population
Cholesterol
(mmol/l)
Chol. $7.8 mmol/l
(%)
Syst. BP.
(mmHg)
Hypertension*
(%)
BMI
(kg/m2)
Obesity
BMI $30 kg/m2(%)
Northern Europe
N. Karelia (SF) 6.0 7 142 36 27.5 23
Turku/Loimaa (SF) 5.9 4 139 33 27.1 22
Iceland 6.2 10 125 18 26.8 16
Glostrup (D) 6.0 5 126 21 26.0 13
Western Europe
Belfast (NI) 5.9 6 135 27 26.3 14
Glasgow (SC) 6.1 6 133 26 26.8 23
Ghent (B) 6.0 6 129 19 26.4 13
Ausburg urban (G) 6.2 10 137 26 27.1 17
Central and Eastern Europe
Warsaw (P) 5.7 3 132 29 27.1 22
Kaunas (L) 6.0 7 137 31 27.1 20
Novi Sad (SE) 6.4 13 136 32 27.3 20
Southern Europe
Friuli (I) 5.9 5 140 27 26.9 17
Brianza (I) 5.9 6 131 25 26.4 14
Catalonia (SP) 5.6 3 121 10 26.7 16
* Hypertension is defined as systolic BP $ 160 mmHg and/or diastolic BP $ 95 Hg and/or antihypertensive medication.
Table 2 Mean levels and annual average change in the period 1985–1995 of biological risk factors for coronary heart disease in men aged
35–64 years in European populations (The WHO MONICA project16)
Population
Tot chol
(mmol/l) Mean
for 1995 survey
Average annual
change
Syst. BP
(mmHg) Mean
for 1995 survey
Average annual
change
BMI (kg/m2)
Mean for 1995
survey
Average annual
change
Northern Europe
N. Karelia (SF) 6.0 20.034 142 20.06 27.5 0.06
Turku/Loimaa (SF) 5.9 20.045 139 20.52 27.1 0.09
Iceland 6.2 0.015 125 0.08 26.8 0.09
Glostrup (D) 6.0 0.001 126 20.08 26.0 0.05
Western Europe
Belfast (NI) 5.9 20.012 135 0.12 26.3 0.06
Glasgow (SC) 6.1 20.011 133 20.70 26.8 0.12
Ghent (B) 6.0 20.026 129 0.37 26.4 0.14
Ausburg urban (G) 6.2 20.013 137 0.24 27.1 0.03
Central and Eastern Europe
Warsaw (P) 5.7 0.020 132 21.35 27.1 0.03
Kaunas (L) 6.0 20.016 137 0.16 27.1 20.07
Novi Sad (SE) 6.4 0.089 136 0.48 27.3 0.07
Southern Europe
Friuli (I) 5.9 20.042 140 20.19 26.9 0.06
Brianza (I) 5.9 0.037 131 20.71 26.4 0.10
Catalonia (SP) 5.6 20.023 121 20.50 26.7 0.09
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The trend in mean systolic blood pressure values is less
clear. A decrease of about 5 mmHg in systolic blood
pressure was observed in North Karelia (Finland) and in
Italy. A large decrease of 15 mmHg in mean systolic blood
pressure was observed when data collected in middle-
aged men in the Netherlands around 1960 were compared
with those of Belgian counterparts examined 25 years
later. Also in the Netherlands a substantial decrease in
systolic blood pressure was noted when middle-aged
men examined around 1960 were compared with those
examined between 1987 and 1991 (141 vs 126 mmHg).
These results suggest that in the Netherlands a substantial
decrease in blood pressure took place between 1960 and
1990. In contrast a 6 mmHg increase was observed in
Serbia. This is compatible with the longitudinal changes
observed in the Serbian cohorts of the Seven Countries
Study18.
A consistent increase in mean BMI was observed in
populations from different parts of Europe. The average
increase varied from 1.3 to 4.5 kg/m2 and corresponds
with an average increase in body weight from 4–14 kg in
a 35 year period. This seems to be an universal
phenomenon in both developed and developing coun-
tries. A global epidemic is developing because of a high
prevalence of physical inactivity and the consumption of
energy dense diets.
Dose-response relationship
The exact nature of the relations between biological risk
factors and cardiovascular diseases is difficult to establish.
Biological risk factors can not be measured without error.
Serum cholesterol can nowadays be measured accurately
(coefficient of variation ,3%) in certified laboratories.
Besides measurement error there is also a substantial
intra- individual variation in biological risk factors. The
intra- individual variation in serum cholesterol on a
constant diet is about 0.5 mmol/l19. Both measurement
error and intra-individual variation should be taken into
account in judging associations between biological risk
factors and coronary heart disease mortality.
The correlation between yearly measurements of serum
cholesterol is about 0.8 and for systolic blood pressure
about 0.7. The correlation between the initial measure-
ments and the measurements at 26 years of follow-up was
in the Framingham Study 0.46 for cholesterol and 0.31 for
systolic blood pressure20. This information can be used to
calculate the so-called regression dilution factor. By
adjusting for regression dilution bias the real strength of
an association between a biological risk factor and disease
occurrence can be calculated.
We calculated regression dilution factors for 6 popula-
tions in the Seven Countries Study12,21. We found that
without correcting for regression dilution the strength of
the association for serum cholesterol and systolic blood
pressure in relation to long-term coronary heart disease
mortality was underestimated with 45% and 60% resp.
This shows the need of repeat measures of biological risk
factors in order to make proper estimates of relations
between biological risk factors and disease endpoints.
All epidemiologic studies showed that the associations
between serum cholesterol and coronary heart disease
and between systolic blood pressure and coronary heart
disease were graded. In the Seven Countries Study we
tested whether the risk ratios for coronary heart disease
mortality were different in relation to a certain increase in
serum cholesterol and systolic blood pressure in different
cultures. We found that for both serum cholesterol and
systolic blood pressure the risk ratios for coronary heart
disease mortality did not differ between cultures12,21.
However substantial differences were found in absolute
risk in different cultures. The absolute risk for long-term
coronary heart disease mortality was 5 times higher in
Northern Europe (Finland and the Netherlands) com-
pared with Mediterranean Southern Europe (Italy and
Greece) at a cholesterol level of 5.2 mmol/l. The same
Table 3 Trends in mean levels of biological risk factors in men with an average age of 50 years in the period 1960–1995 in European
populations14–16,*
Cholesterol (mmol/l) Syst.BP (mmHg) BMI (kg/m2)
Place 1960 1985 1995 1960 1985 1995 1960 1985 1995
North Karelia (SF) 6.8 6.4 6.0 146 144 142 23.0 26.9 27.5
Turku/Loimaa (SF) 6.5 6.2 5.9 138 143 139 23.7 26.9 27.1
Zutphen (NL) 6.0 141 24.0
Ghent (B) 6.1 6.0 127 129 26.1 26.4
Zrenjanin (SE) 4.3 130 24.7
Novi Sad (SE) – 6.4 135 136 26.7 27.3
Crevalcore (I) 5.1 145 25.6
Friuli (I) 6.3 5.9 142 140 26.6 26.9
Montegiorgio (I) 5.1 135 23.9
Brianza (I) 5.6 5.9 137 131 25.7 26.4
* The 1960 data are the baseline data of the Seven Countries Study. The 1985 and 1995 data are of the WHO MONICA project.
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holds for systolic blood pressure. At a level of 140 mmHg
the absolute risk is about 3 times higher in Northern
Europe compared to Mediterranean Southern Europe.
These results have great implications from a public
health point of view. Prevention and treatment of a
certain serum cholesterol or blood pressure level is
associated with a greater health effect in Northern Europe
than in Southern Europe, assuming a similar reduction in
risk factors in these regions. The formulation of different
target levels for serum cholesterol and blood pressure
lowering in Northern and Southern Europe should
therefore be considered.
Another point of consideration is that serum cholesterol
or blood pressure lowering alone for persons at high risk
is not enough. A global risk score based on the major
coronary heart disease risk factors should be calculated as
advised by the European Society of Cardiology22. Those
at high risk should lower serum cholesterol and blood
pressure below the target values. However, in Northern
Europe that is not enough. Improvement of the diet e.g. a
low intake of saturated and trans fatty acids and an
adequate intake of poly-unsaturated fatty acids and
antioxidants, may be necessary in order to achieve a
risk as low as in the Mediterranean countries.
Behavioural risk factors of cardiovascular diseases
Because of the large variation in the mortality from
coronary heart disease and stroke it is likely that
behavioural risk factors play an important role in the
etiology of these diseases. The emphasis will be on
dietary determinants of coronary heart disease because
much less is known about the dietary determinants of
stroke. Different behavioural risk factors are closely
intertwined. Therefore besides diet also attention will be
paid to alcohol, smoking and physical activity. Finally
attention will be paid to the interaction between
behavioural risk factors and genetic factors.
Fatty acids and coronary heart disease
In 1952 Keys hypothesised that serum cholesterol is a
major determinant of coronary heart disease23. At that
time it was thought that dietary cholesterol and total fat
were the major determinants of serum cholesterol. Later
on it became clear that not dietary cholesterol and total fat
but individual fatty acids especially saturated fatty acids
with 12–16 carbon atoms were the most important
determinants of serum cholesterol. These fatty acids
have a strong cholesterol elevating effect and were at
the population level strongly related to long-term
coronary heart disease mortality24.
In prospective cohort studies generally weaker associa-
tions are observed between the intake of saturated fat,
serum cholesterol and coronary heart disease than
expected from experimental studies25. This effect may
be real but can also be due to the inaccurate measurement
of saturated fat intake in observational studies. Saturated
fat is present in a lot of foods and in complex dishes like
gravy. This may be a reason why an accurate estimate of
the intake of saturated fat is difficult to obtain in everyday
life.
During the hardening process of polyunsaturated fatty
acid rich oils for margarine production so-called trans
fatty acids are formed. Controlled dietary experiments
have shown that especially the trans fatty acid elaidic acid
has a total and LDL cholesterol elevating effect and a HDL
cholesterol lowering effect26. The HDL cholesterol low-
ering effect of elaidic acid seems to be confined to high
intake levels. In the Seven Countries Study the population
intake of elaidic acid was significantly related to long-term
coronary heart disease mortality24. Also at the individual
level the intake of trans fatty acids was positively
associated with the occurrence of coronary heart disease
as was shown in the Nurses Health Study27.
Cis mono-unsaturated fatty acids present in e.g. olive
oil and margarine’s, lower total and LDL cholesterol
compared with saturated fatty acids and do not, in
contrast to carbohydrates, lower HDL cholesterol. This
is the reason that some scientists prefer these mono-
unsaturated fatty acids above carbohydrates for total and
LDL cholesterol lowering28. However, there is no obser-
vational epidemiologic and clinical trial evidence that a
diet low in saturated fat and high in cis monounsaturated
fat compared to a diet low in saturated fat and high in
carbohydrates and dietary fiber is superior in relation to
the occurrence of coronary heart disease. More evidence
is needed before definite statements on this issue can be
made.
Polyunsaturated fatty acids consist of two parent
compounds: linoleic acid, a fatty acid of the N-6 family
with 18 carbon atoms and two double bonds and a-
linolenic acid, a fatty acid of the N-3 family with 18 carbon
atoms and 3 double bonds. These fatty acids have
different metabolic effects. Linoleic acid (LA) can be
elongated to arachidonic acid (AA), a fatty acid with 20
carbon atoms and 4 double bonds. a-Linolenic acid can
be elongated to either eicosapentaenoic acid (EPA), a fatty
acid with 20 carbon atoms and 5 double bonds or
docosahexaenoic acid (DHA), a fatty acid with 22 carbon
atoms and 6 double bonds. The fatty acids with 20 carbon
atoms, AA and EPA, play an important role in prostaglan-
din metabolism and may influence the thrombotic
process.
In Western European populations with an average
intake of linoleic acid of more than 4% of energy no
association between linoleic acid intake and coronary
heart disease is observed. In earlier days an inverse
association between linoleic acid and coronary heart
disease was observed in countries with a low intake of
linoleic acid e.g. Finland and Scotland.
In prospective cohort studies evidence is accumulating
that the intake of a-linolenic acid is inversely related with
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coronary heart disease29. However, whether this effect is
independent of other unsaturated fatty acids e.g. linoleic
acid, is difficult to establish because different unsaturated
fatty acids are present in the same foods e.g. soybean oil.
However, the hypothesis of a protective effect of a-
linolenic acid in relation to coronary heart disease is
supported by the results of the Lyon trial. In this
intervention study a Mediterranean diet enriched with
a-linolenic acid was strongly protective in relation to
coronary heart disease30. However, more information is
needed before definite statements can be made about the
possible protective effect of a-linolenic acid.
Fish is an important source of the N-3 fatty acids EPA
and DHA. We found in two prospective studies carried
out in the Netherlands that a small amount of fish protects
against coronary heart disease mortality31,32. This associa-
tion was also observed in several other prospective
studies but not in all33. The association was found in
cultures with a low fish intake especially if persons who
did not consume fish were compared with those who
consumed fish once a week. The association also
depends on the endpoint. Associations are observed for
hard endpoints e.g. coronary mortality or cardiac arrest
but not for softer endpoints e.g. non-fatal coronary heart
disease. There is now also evidence from two interven-
tion trials that cardiac patients who eat at least twice a
week fatty fish or take a supplement of 1 gram of N-3
polyunsaturated fatty acids per day are protected against
coronary heart disease mortality34,35. It can be concluded
that consumption of fish once or twice a week is
protective in relation to coronary heart disease mortality.
Antioxidants and coronary heart disease
Research on antioxidants has traditionally been focused
on (pro-) vitamins with antioxidant properties e.g.
tocopherols (vitamin E), carotenoids (b-carotene) and
vitamin C. Besides these so-called nutritive antioxidants
there are also non-nutritive antioxidants. Non-nutritive
substances are compounds in foods without nutritional
value. Recently it became clear that especially plant foods
contain numerous compounds with strong antioxidant
properties e.g. polyphenols. Important examples are
flavonols e.g. quercetin that is present in onions and
apples and catechins e.g. epigallocatechin that is present
in tea. The associations between (non)-nutritive antiox-
idants and coronary heart disease will be summarised.
In case-control studies convincing associations
between the vitamin E concentration in blood or adipose
tissue and coronary heart disease have not been shown.
In five prospective studies inverse associations were
observed between vitamin E intake and coronary heart
disease risk36–40. However, in three studies this associa-
tion was noted for supplement users and in two studies
for the vitamin E content in the diet. In three secondary
prevention trials the hypothesis was tested whether
vitamin E supplementation could prevent re-infarction
and mortality. In one trial vitamin E supplementation
prevented re-infarctions but not mortality41. In the other
two trials no effect of vitamin E supplementation was
observed35,42. It can be concluded that the evidence for a
relation between vitamin E and coronary heart disease is
not convincing.
Generally no association was observed between b-
carotene and coronary heart disease in observational
studies38,39,40,43. One study found a protective effect of b-
carotene on coronary heart disease in smokers37. In three
large intervention trials mainly carried out in smokers no
association was observed between supplementation of b-
carotene and cardiovascular mortality44–46. In prospective
studies no association was observed between vitamin C
intake and coronary heart disease. Controlled trials on the
association between vitamin C intake and coronary heart
disease have not been carried out. It can be concluded
that there is no convincing evidence for relations between
either b-carotene or vitamin C and coronary heart disease.
In 1993 we published a paper showing an inverse
relation between the intake of flavonols and the 5-year
mortality from coronary heart disease in the Zutphen
Elderly Study47. This association was also present when
the follow-up period was extended to 10 years. The
association between flavonol intake and coronary heart
disease was also studied in three prospective studies
carried out in Finland, USA and Wales48–50. One found an
inverse association and two did not find a relation. It can
be concluded that the association between flavonol intake
and coronary heart disease is promising but more data are
needed before definite conclusions can be drawn.
In the Seven Countries Study the association between
the intake of different antioxidants and long-term
coronary heart disease mortality was studied at the
population level51,52. The average population intake of
vitamin E, b-carotene and vitamin C was not related to 25-
year coronary heart disease mortality rates51. However,
the average population intake of flavonols was inversely
related with 25-year coronary heart disease mortality
rates52. These results are generally spoken in accord with
those of case-control and cohort studies.
Diet and blood pressure
Blood pressure is an important determinant of different
cardiovascular diseases e.g. coronary heart disease, stroke
and kidney failure. In Western societies an increase in
blood pressure with age is noted53. This increase in blood
pressure is an important determinant of the occurrence in
cardiovascular diseases. Therefore, there is a great interest
in preventing the increase in blood pressure with age.
In so-called primitive societies as the Yanomamo
Indians in Brazil, no increase in blood pressure with age
is noted53. This is generally ascribed to the low sodium
intake of these populations. However they have also a
high intake of plant foods, are physically active, drink less
alcohol and are leaner than their Western counterparts.
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This suggests that factors other than a low sodium intake
may explain these low blood pressure levels. This also
holds for the so-called Kempner rice-fruit diet that is used
in the treatments of hypertension since the 1940s. Apart
from being low in sodium, this diet is also high in
potassium, low in energy and alcohol.
Recently a paradigm shift is occurring in relation to diet
and blood pressure. Recent meta-analysis and trials show
only a modest effect of sodium reduction in relation to
blood pressure lowering54. At the same time the DASH
trial showed that with dietary changes a 5–6 mmHg lower
systolic blood pressure in subjects with normal blood
pressure and of 11–12 mmHg in persons with mild
hypertension could be obtained55. The diet used in this
trial was rich in low-fat dairy products, fruits and
vegetables and therefore high in potassium, magnesium
and calcium. These results suggest that a high intake of
plant foods in combination with low-fat dairy products
may substantially decrease blood pressure and has a
greater effect than reductions in sodium intake such as
can be achieved in Western societies. Currently the effect
of the DASH- diet in combination with sodium reduction
is tested in an intervention trial.
Smoking, alcohol and physical activity
Smoking is the most important determinant of chronic
diseases like different cardiovascular diseases, different
types of cancer and chronic respiratory diseases. Lopez
and Murray calculated that in 1990 world-wide 3.0 million
deaths out of a total of 50.5 million could be attributed to
tobacco6. They projected that this number will increase to
8.4 million by the year 2020. This shows that tobacco is a
major killer and that the toll of tobacco smoking will
almost triple within a 30-year time period.
The relationships between alcohol consumption, cor-
onary heart disease and stroke mortality are complex.
Many studies have shown that persons who do not
consume alcohol and those with a high level of
consumption are at a higher risk for cardiovascular
diseases than moderate alcohol users. In this context
also the association between alcohol intake and other
causes of death is of importance. The question is what
level of alcohol intake is compatible with the lowest
mortality.
A large prospective study carried out among US adults
showed that cardiovascular mortality was 30 to 40% lower
among persons who reported at least one drink daily
compared to non drinkers56. All cause mortality was
lowest among those who reported one drink daily. These
results suggest that a moderate level of alcohol consump-
tion is equivalent to having one drink a day. Also a
recently published study carried out in cardiac patients,
suggests that one drink per day is associated with the
lowest mortality57.
The evidence on physical activity and health has been
summarised in a report of the Surgeon General of the
USA58. Meta-analyses suggest that in studies of a higher
quality the relative risk was 1.8 for persons with the
lowest level of physical activity compared with those of
the highest level of physical activity. Therefore the
American College of Sport Medicine advises to take at
least 30 minutes of physical activity e.g. walking and
biking, on a daily basis. Because of the high prevalence of
inactive people in Western societies an increase in
physical activity will have a large public health impact.
This short summary shows that no smoking, moderate
alcohol intake and regular physical activity are important
components of a healthy life style.
Interactions between genetic and behavioural risk
factors
A positive family history is a risk factor for coronary heart
disease. Persons who have a father or mother who died
before age 60 from coronary heart disease have a two times
higher risk of dying from coronary heart disease compared
with persons who do not have a positive family history.
These results suggest that genetic factors are an important
determinant of an individual’s chance to develop coronary
heart disease. This has been known for a long time in
relation to monogenetic traits like familial hypercholester-
olemia. However, monogenetic traits are uncommon in the
population. From a public health point of view the
polygenetic traits and their interactions with behavioural
risk factors are more important because they are much
more common in the population.
We studied the interaction between genetic and lifestyle
factors e.g. physical activity, alcohol and smoking in
relation to blood lipids and lipoproteins59. We found that
a mutation in the LPL gene (D9N) increased the apo B and
LDL cholesterol levels. However, this increase could be
counteracted by physical activity. Physically active per-
sons with this mutation had similar apo B and LDL
cholesterol levels compared to persons who did not have
this mutation.
We also found that moderate alcohol consumers with
the CETP B2B2 genotype had higher HDL cholesterol
levels compared with subjects having other genotypes.
These results suggest that moderate alcohol consumption
strengthens a genetic predisposition for high HDL
cholesterol levels. Smokers with the apo C III S1S2
genotype had higher level of triglycerides and apo B
compared with the S1S1 genotype. This was not observed
among non-smokers. Smoking may therefore deteriorate
the effect of a predisposition to unfavourable lipid levels.
These results suggest that important interactions
between genetic and behavioural risk factors in relation
to blood lipids exist. To unravel these complex interac-
tions it is necessary to get more insight into the role of
different factors in predicting coronary heart disease risk.
Ultimately this may lead to more specific advice on
behavioural risk factors for persons with certain genetic
traits.
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Dietary prevention of cardiovascular diseases
We have shown that diet is an important determinant of
biological risk factors e.g. blood lipids and blood
pressure, and of cardiovascular diseases. Some effects of
diet are due to an effect on biological risk factors e.g. the
effect of fatty acids on serum total and LDL cholesterol but
diet can also have effects independent of serum
cholesterol e.g. effects of N-3 polyunsaturated fatty acids
such as a-linolenic acid and eicosapentaenoic acid on e.g.
membrane fluidity and ventricular fibrillation. In order to
get a complete picture of the effect of dietary interven-
tions the different aspects of diet on biological risk factors
and the direct effects of diet on cardiovascular endpoints
should be evaluated.
An important point to consider is the difference in
effects of diet on biological risk factors and cardiovascular
diseases under controlled conditions such as clinical trials
and under ordinary living conditions. In this context the
terms efficacy (health gain under optimal e.g. trial
conditions) and effectiveness (health gain under ordinary
living conditions) are of importance. In the latter category
the results of both intervention studies under free-living
conditions and of trend studies in populations will be
dealt with.
In uni and multifactorial intervention trials carried out
in the 1960’s an 1970’s saturated fatty acids were
exchanged for poly-unsaturated fatty acids especially
linoleic acid60. In 14 primary and secondary prevention
trials an average reduction in serum total cholesterol of
about 10% was obtained. This was associated with a 13%
reduction in the occurrence of coronary events and a 6%
reduction in all cause mortality. The five trials with the
largest serum cholesterol reduction showed an average
decrease in serum cholesterol of 13%. This decrease was
associated with a 30% decrease in coronary events and a
11% decrease in mortality from all causes. Later trials
carried out in the 1980’s and 1990’s did not lower serum
cholesterol but intervened on specific fatty acids e.g. by
increasing fatty fish consumption (DART-trial), a-linolenic
acid intake (Lyon trial), by supplementation with eicosa-
pentaenoic acid and docosahexaenoic acid (GISSI-P-trial),
or by increasing the consumption of fruits and vegetables
(Indian trial)30,34,35,61. These trials were carried out in
cardiac patients and especially the trials using dietary
interventions showed larger effects on coronary heart
disease and all cause mortality than the earlier trials on
cholesterol lowering. In these trials cardiac mortality was
reduced by 33–76% and all cause mortality by 29–70%.
The largest effect was seen on sudden death. These
results show clearly that not only cholesterol lowering is
of importance. A healthy well balanced diet has more
effects than serum cholesterol lowering alone.
What can be achieved by dietary interventions in
everyday practice? A recent meta-analysis of 17 rando-
mised controlled trials on dietary behaviour intervention
of a least 3 months duration showed a net change in total
cholesterol of 20.22 mmol/l or approximately 3%62. A
decrease of 245.0 mmol urinary sodium /24 hours was
associated with a non-significant decrease in systolic
blood pressure of 21.9 (1%) and in diastolic blood
pressure of 21.2 mmHg (1%). These results show that
dietary behaviour intervention in primary prevention can
achieve modest improvements in diet and biological risk
factor status.
These results seem rather disappointing. Only small risk
factor reductions can be obtained in free living subjects.
However if changes in the dietary pattern of a whole
society occur, impressive changes can be obtained. A
well-known example in this context is Finland63. Between
1972 and 1992 a 13% decrease in serum cholesterol took
place because of the change from butter to vegetable oil
margarine’s, from whole fat milk to low fat milk and from
boiled to filtered coffee. There was also a 9% decrease in
blood pressure probably because of a reduction in
sodium intake and an increase in fruit and vegetable
consumption. These changes in serum cholesterol and
blood pressure contributed for a large extent to the 55%
decline in coronary heart disease mortality in men and the
68% decline in women.
The results from Finland show that changes in dietary
habits in the whole population are probably easier to
achieve than changes in the diet of subgroups e.g. high
risk persons within a society. If the whole society changes
its dietary pattern every person or a large majority
changes its behaviour. This is in that case socially
acceptable. If only a few high risk persons have to
change their diet they have to deviate from the usual
dietary pattern in the general population and that is much
more difficult to achieve. That impressive changes can be
realised in the population can also be shown by results
from the Zutphen Study. In 1960 about 70% of the
participants ate white bread. Twenty five years later this
percentage was reduced to 30% and 70% ate brown or
wholemeal bread.
The latest development in relation to food consumption
is the introduction of functional foods on the markets.
These foods have been enriched with a constituent of
which the producer claims that it is of health benefit for
the consumer. An example is the introduction of
margarine’s enriched with plant sterols or stanols. If this
spread is used in ordinary amounts the user will get an
intake of 1–3 grams of plant sterols or stanols per day.
This decreases total and LDL cholesterol by about 10%
and does not influence HDL cholesterol64. Because of this
total and LDL cholesterol lowering effect the risk of an
individual for getting a coronary event may decrease on
average by 20–30%.
Can the introduction of functional foods on the market
be viewed as a positive development? The advantage as in
the case of margarine’s enriched with plant sterols or
stanols is that the risk of an individual for coronary heart
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disease decreases. There may also be side effects such as
the 10–20% decrease in plasma carotenoids. As far as we
know at the moment, plasma carotenoids are not
convincingly associated with coronary heart disease or
other chronic diseases. However, not all evidence is
available yet and we may have to change our opinion in
the future. Another aspect to consider in this context is
that the average decrease in carotenoids is 10–20% but in
persons with a higher than average bread consumption
larger decreases in total and LDL cholesterol and in
carotenoids may be obtained by a higher than average
intake of the plant sterol containing margarine’s. We do
not know what the health consequences are of a decrease
of e.g. 20–40% in plasma carotenoids.
Evidence is accumulating that a well balanced diet has a
large preventive potential. This means not only a diet low
in saturated and trans fatty acids but also regular
consumption of fish and a diet rich in plant foods. We
have shown in the Finnish, Dutch and Italian cohorts of
the Seven Countries Study that men who complied best to
a healthy diet indicator based on guidelines of the WHO
had the best survival in all three countries65. Even in the
case of a Mediterranean diet as used in Italy, it was shown
that also there a relation exists between the quality of the
Mediterranean diet and survival. This was also found in a
study from Greece66. It is therefore of great importance to
define a healthy food pattern.
It is frequently thought that a healthy diet is only of
importance in relation to primary prevention of cardio-
vascular diseases. The secondary prevention trials carried
out in cardiac patients have clearly shown that they
benefit substantially from dietary changes e.g. an
increased consumption of fatty fish, a-linolenic enriched
margarines, fruit and vegetables30,34,61. In these trials the
reduction in all cause mortality was larger than in the trials
in which statins were used for cholesterol lowering67. It
may therefore be concluded that a well balanced diet is of
importance for both primary and secondary prevention of
cardiovascular diseases.
In relation to prevention of cardiovascular diseases a
healthy diet is recommended22, characterised by
X a low intake of saturated fatty acids (less than 10
percent of energy/day).
X a low intake of trans fatty acids (less than 2 percent/
day)
X at least 4 percent/d of energy of linoleic acid,
2 grams/day a-linolenic acid and 200 milligrams/day
of very long chain N-3 polyunsaturated fatty acids
X at least 400 grams/day of fruits and vegetables
X a salt intake of less than 6 grams/day.
Conclusions
This short overview shows that cardiovascular diseases
e.g. coronary heart disease and stroke are and will be for
the next 20 years the major causes of death in Europe. In
spite of decreasing mortality rates the number of
cardiovascular patients will increase because of the
ageing population and successful treatment. Diet is an
important determinant of biological risk factors for
cardiovascular diseases e.g. serum cholesterol and blood
pressure. However, dietary constituents may also exert an
influence on these diseases independent of these risk
factors. Based on the results of observational epidemiol-
ogy, controlled dietary intervention studies and primary
and secondary prevention trials it can be concluded that a
diet low in saturated and trans fatty acids and rich in plant
foods in combination with regular fish consumption is
associated with the lowest risk for cardiovascular and all
cause mortality. Diet is not the only behavioural risk
factor of importance in this context. In addition to a well
balanced diet, the advice should be not to smoke, to use
alcohol in moderation and to stay physically active. If this
advice is put into practice both quantity and quality of life
of both persons free of cardiovascular diseases and of
cardiovascular patients can be improved.
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